摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzoic acid | 926230-39-9

中文名称
——
中文别名
——
英文名称
3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzoic acid
英文别名
3-{4H,5H,6H,7H-thieno[3,2-c]pyridine-5-sulfonyl}benzoic acid;3-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-ylsulfonyl)benzoic acid
3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzoic acid化学式
CAS
926230-39-9
化学式
C14H13NO4S2
mdl
MFCD09050829
分子量
323.394
InChiKey
KOKBEXZEABMYFP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    569.0±60.0 °C(Predicted)
  • 密度:
    1.493±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.214
  • 拓扑面积:
    111
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzoic acid硫酸一水合肼 作用下, 以 甲醇乙醇 为溶剂, 反应 32.0h, 生成 N'-[(E)-(4-chlorophenyl)methylidene]-3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzohydrazide
    参考文献:
    名称:
    Synthesis and Antibacterial Activity of Hydrazone Derivatives Bearing 3-(6,7-Dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzoicacid Scaffold
    摘要:
    本研究描述了从商业可获得的4,5,6,7-四氢噻吩[3,2-c]吡啶(1)合成的3-(6,7-二氢噻吩[3,2-c]吡啶-5(4H)-基磺酰基)苯肼衍生物(7a-p),并研究了其抗菌活性。通过核磁共振(1H NMR)、红外光谱(IR)和质谱分析对合成化合物7a-p进行了表征。这些合成化合物在琼脂孔扩散法下对革兰氏阴性和革兰氏阳性菌株进行了测试,包括:(i)大肠杆菌(MTCC 443)、(ii)铜绿假单胞菌(MTCC 424)、(iii)金黄色葡萄球菌(MTCC 96)和(iv)化脓性链球菌(MTCC 442)。化合物7g(R = 2-OH, 4-OCHF2)、7h(R = 2-NO2)、7i(R = 3-NO2)、7j(R = 4-NO2)和7n(4-OH)对革兰氏阳性和阴性菌株均表现出优异的抗菌活性(抑菌圈直径:25-32毫米)。化合物7f(R = 2-F, 3-Cl)、7k(R = 2-OMe)、7l(R = 4-OMe)、7m(R = 4-OEt)、7o(R = 3-OMe)、7p(R = 3,4-OEt)显示出良好的抗菌活性(抑菌圈直径:19-26毫米)。
    DOI:
    10.14233/ajchem.2015.18877
  • 作为产物:
    描述:
    3-氯磺酰基苯甲酸4,5,6,7-四氢噻吩[3,2-c]吡啶盐酸盐丙酮 为溶剂, 以31%的产率得到3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzoic acid
    参考文献:
    名称:
    3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: Highly Potent and Selective Inhibitors of the Type 5 17-β-Hydroxysteroid Dehydrogenase AKR1C3
    摘要:
    A high-throughput screen identified 3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acid as a novel, highly potent (low nM), and isoform-selective (1500-fold) inhibitor of aldo-keto reductase AKR1C3: a target of interest in both breast and prostate cancer. Crystal structure studies showed that the carboxylate group occupies the oxyanion hole in the enzyme, while the sulfonamide provides the correct twist to allow the dihydroisoquinoline to bind in an adjacent hydrophobic pocket. SAR studies around this lead showed that the positioning of the carboxylate was critical, although it could be substituted by acid isosteres and amides. Small substituents on the dihydroisoquinoline gave improvements in potency. A set of "reverse sulfonamides" showed a 12-fold preference for the R stereoisomer. The compounds showed good cellular potency, as measured by inhibition of AKR1C3 metabolism of a known dinitrobenzamide substrate, with a broad rank order between enzymic and cellular activity, but amide analogues were more effective than predicted by the cellular assay.
    DOI:
    10.1021/jm3007867
点击查看最新优质反应信息

文献信息

  • 3-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-ylsulfonyl)benzoic Acids: Highly Potent and Selective Inhibitors of the Type 5 17-β-Hydroxysteroid Dehydrogenase AKR1C3
    作者:Stephen M. F. Jamieson、Darby G. Brooke、Daniel Heinrich、Graham J. Atwell、Shevan Silva、Emma J. Hamilton、Andrew P. Turnbull、Laurent J. M. Rigoreau、Elisabeth Trivier、Christelle Soudy、Sharon S. Samlal、Paul J. Owen、Ewald Schroeder、Tony Raynham、Jack U. Flanagan、William A. Denny
    DOI:10.1021/jm3007867
    日期:2012.9.13
    A high-throughput screen identified 3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acid as a novel, highly potent (low nM), and isoform-selective (1500-fold) inhibitor of aldo-keto reductase AKR1C3: a target of interest in both breast and prostate cancer. Crystal structure studies showed that the carboxylate group occupies the oxyanion hole in the enzyme, while the sulfonamide provides the correct twist to allow the dihydroisoquinoline to bind in an adjacent hydrophobic pocket. SAR studies around this lead showed that the positioning of the carboxylate was critical, although it could be substituted by acid isosteres and amides. Small substituents on the dihydroisoquinoline gave improvements in potency. A set of "reverse sulfonamides" showed a 12-fold preference for the R stereoisomer. The compounds showed good cellular potency, as measured by inhibition of AKR1C3 metabolism of a known dinitrobenzamide substrate, with a broad rank order between enzymic and cellular activity, but amide analogues were more effective than predicted by the cellular assay.
  • Synthesis and Antibacterial Activity of Hydrazone Derivatives Bearing 3-(6,7-Dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzoicacid Scaffold
    作者:Gowrisankar Rao Kaki、B. Sreenivasulu、Aminul Islam、Dussa Nageshwar、Raghubabu Korupolu、B. Venkateshwara Rao
    DOI:10.14233/ajchem.2015.18877
    日期:——
    The present work describes the synthesis and antibacterial activity of 3-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)benzohydrazide derivatives (7a-p) prepared from commercially available 4,5,6,7-tetrahydrothieno[3,2-c]pyridine (1). They were characterized by 1H NMR, IR and mass spectral analysis. The synthesized compounds 7a-p, were tested against Gram negative and Gram positive bacterial strains viz; (i) Escherichia coli (MTCC 443), (ii) Pseudomonas aeruginosa (MTCC 424) (iii) Staphylococcus aureus (MTCC 96) and (iv) Streptococcus pyogenes (MTCC 442) using agar well diffusion method. Compounds 7g (R = 2-OH, 4-OCHF2), 7h (R = 2-NO2), 7i (R = 3-NO2), 7j (R = 4-NO2) and 7n (4-OH) displayed excellent antibacterial activity (zone of inhibition: 25-32 mm) against both the Gram positive and Gram negative bacterial strains. Compounds 7f (R = 2-F, 3-Cl), 7k (R = 2-OMe), 7l (R = 4-OMe), 7m (R = 4-OEt), 7o (R = 3-OMe), 7p (R = 3,4-OEt) showed good antibacterial activity (zone of inhibition: 19-26 mm).
    本研究描述了从商业可获得的4,5,6,7-四氢噻吩[3,2-c]吡啶(1)合成的3-(6,7-二氢噻吩[3,2-c]吡啶-5(4H)-基磺酰基)苯肼衍生物(7a-p),并研究了其抗菌活性。通过核磁共振(1H NMR)、红外光谱(IR)和质谱分析对合成化合物7a-p进行了表征。这些合成化合物在琼脂孔扩散法下对革兰氏阴性和革兰氏阳性菌株进行了测试,包括:(i)大肠杆菌(MTCC 443)、(ii)铜绿假单胞菌(MTCC 424)、(iii)金黄色葡萄球菌(MTCC 96)和(iv)化脓性链球菌(MTCC 442)。化合物7g(R = 2-OH, 4-OCHF2)、7h(R = 2-NO2)、7i(R = 3-NO2)、7j(R = 4-NO2)和7n(4-OH)对革兰氏阳性和阴性菌株均表现出优异的抗菌活性(抑菌圈直径:25-32毫米)。化合物7f(R = 2-F, 3-Cl)、7k(R = 2-OMe)、7l(R = 4-OMe)、7m(R = 4-OEt)、7o(R = 3-OMe)、7p(R = 3,4-OEt)显示出良好的抗菌活性(抑菌圈直径:19-26毫米)。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐